
Fresh additions to the Afya Chain catalogue, ready for discovery and procurement.
Formulations: - Local > Nasal > Spray: 32 µg per actuation; 64 µg per actuation Indications: - Allergic rhinitis Source: EML workbook import
Formulations: - Respiratory > Inhalation > powder: 100 µg + 6 µg per dose actuation in dry powder inhaler; 200 µg + 6 µg per dose actuation in dry powder inhaler Indications: - Asthma Source: EML workbook import
Indications: - Asthma Source: EML workbook import
Indications: - Chronic obstructive pulmonary disease Source: EML workbook import
Formulations: - Respiratory > Inhalation > solution: 20 µg per actuation in pressurized metered dose inhaler Indications: - Asthma - Chronic obstructive pulmonary disease Source: EML workbook import
Ready to amplify your rewards? Drop your email and we'll be in touch soon.